newsfilter
← Latest News
GlobeNewswire·

RVL Pharmaceuticals plc to Discuss First Quarter 2022 Financial Results and Provide Commercial Update

BRIDGEWATER, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (NASDAQ:RVLP) ("RVL" or the "Company"), a specialty pharmaceutical company, today announced that the Company will release its first quarter 2022 financial results and provide a